scispace - formally typeset
Search or ask a question
Institution

Cardiff University

EducationCardiff, United Kingdom
About: Cardiff University is a education organization based out in Cardiff, United Kingdom. It is known for research contribution in the topics: Population & Context (language use). The organization has 34188 authors who have published 82643 publications receiving 3046531 citations. The organization is also known as: University of Cardiff & University College of South Wales and Monmouthshire.


Papers
More filters
Journal ArticleDOI
TL;DR: The data show an exosome-mediated mechanism of skewing IL-2 responsiveness in favor of regulatory T cells and away from cytotoxic cells, which strongly implicates the role of exosomes in tumor immune evasion.
Abstract: Exosomes are nanometer-sized vesicles, secreted by normal and neoplastic cells. The outcome following interaction between the cellular immune system and cancer-derived exosomes is not well understood. Interleukin-2 (IL-2) is a key factor supporting expansion and differentiation of CTL and natural killer (NK) cells but can also support regulatory T cells and their suppressive functions. Our study examined whether tumor-derived exosomes could modify lymphocyte IL-2 responses. Proliferation of healthy donor peripheral blood lymphocytes in response to IL-2 was inhibited by tumor exosomes. In unfractionated lymphocytes, this effect was seen in all cell subsets. Separating CD4(+) T cells, CD8(+) T cells, and NK cells revealed that CD8(+) T-cell proliferation was not inhibited in the absence of CD4(+) T cells and that NK cell proliferation was only slightly impaired. Other exosome effects included selective impairment of IL-2-mediated CD25 up-regulation, affecting all but the CD3(+)CD8(-) T-cell subset. IL-2-induced Foxp3 expression by CD4(+)CD25(+) cells was not inhibited by tumor exosomes, and the suppressive function of CD4(+)CD25(+) T cells was enhanced by exosomes. In contrast, exosomes directly inhibited NK cell killing function in a T-cell-independent manner. Analysis of tumor exosomes revealed membrane-associated transforming growth factor beta(1) (TGFbeta(1)), which contributed to the antiproliferative effects, shown by using neutralizing TGFbeta(1)-specific antibody. The data show an exosome-mediated mechanism of skewing IL-2 responsiveness in favor of regulatory T cells and away from cytotoxic cells. This coordinated "double hit" to cellular immunity strongly implicates the role of exosomes in tumor immune evasion.

504 citations

Journal ArticleDOI
Günter U. Höglinger1, Nadine M. Melhem2, Dennis W. Dickson3, Patrick M. A. Sleiman4, Li-San Wang4, Lambertus Klei2, Rosa Rademakers3, Rohan de Silva5, Irene Litvan6, David E. Riley7, John C. van Swieten8, Peter Heutink9, Zbigniew K. Wszolek3, Ryan J. Uitti3, Jana Vandrovcova5, Howard I. Hurtig4, Rachel G. Gross4, Walter Maetzler10, Stefano Goldwurm, Eduardo Tolosa11, Barbara Borroni12, Pau Pastor13, Laura B. Cantwell4, Mi Ryung Han4, Allissa Dillman14, Marcel P. van der Brug15, J. Raphael Gibbs5, J. Raphael Gibbs14, Mark R. Cookson14, Dena G. Hernandez5, Dena G. Hernandez14, Andrew B. Singleton14, Matthew J. Farrer16, Chang En Yu17, Lawrence I. Golbe18, Tamas Revesz5, John Hardy5, Andrew J. Lees5, Bernie Devlin2, Hakon Hakonarson4, Ulrich Müller19, Gerard D. Schellenberg4, Roger L. Albin20, Elena Alonso13, Angelo Antonini, Manuela Apfelbacher21, Steven E. Arnold4, Jesús Avila22, Thomas G. Beach, Sherry Beecher4, Daniela Berg23, Thomas D. Bird, Nenad Bogdanovic24, Agnita J.W. Boon8, Yvette Bordelon25, Alexis Brice26, Alexis Brice27, Herbert Budka28, Margherita Canesi, Wang Zheng Chiu8, Roberto Cilia, Carlo Colosimo29, Peter Paul De Deyn30, Justo Garcãa De Yebenes, Laura Donker Kaat8, Ranjan Duara31, Alexandra Durr26, Alexandra Durr27, Sebastiaan Engelborghs30, Giovanni Fabbrini29, Nicole A. Finch3, Robyn Flook32, Matthew P. Frosch33, Carles Gaig11, Douglas Galasko34, Thomas Gasser23, Marla Gearing35, Evan T. Geller4, Bernardino Ghetti36, Neill R. Graff-Radford3, Murray Grossman4, Deborah A. Hall37, Lili-Naz Hazrati38, Matthias Höllerhage1, Joseph Jankovic39, Jorge L. Juncos35, Anna Karydas40, Hans A. Kretzschmar41, Isabelle Leber26, Isabelle Leber27, Virginia M.-Y. Lee4, Andrew P. Lieberman20, Kelly E. Lyons42, Claudio Mariani, Eliezer Masliah34, Luke A. Massey5, Catriona McLean43, Nicoletta Meucci, Bruce L. Miller40, Brit Mollenhauer44, Jens Carsten Möller1, Huw R. Morris45, Christopher Morris46, Sean S. O'Sullivan5, Wolfgang H. Oertel1, Donatella Ottaviani29, Alessandro Padovani12, Rajesh Pahwa42, Gianni Pezzoli, Stuart Pickering-Brown47, Werner Poewe48, Alberto Rábano49, Alex Rajput50, Stephen G. Reich51, Gesine Respondek1, Sigrun Roeber41, Jonathan D. Rohrer5, Owen A. Ross3, Martin N. Rossor5, Giorgio Sacilotto, William W. Seeley40, Klaus Seppi48, Laura Silveira-Moriyama5, Salvatore Spina36, Karin Srulijes23, Peter St George-Hyslop52, Maria Stamelou1, David G. Standaert53, Silvana Tesei, Wallace W. Tourtellotte54, Claudia Trenkwalder44, Claire Troakes55, John Q. Trojanowski4, Juan C. Troncoso56, Vivianna M. Van Deerlin4, Jean Paul G. Vonsattel57, Gregor K. Wenning48, Charles L. White58, Pia Winter19, Chris Zarow59, Anna Zecchinelli 
University of Marburg1, University of Pittsburgh2, Mayo Clinic3, University of Pennsylvania4, University College London5, University of Louisville6, Case Western Reserve University7, Erasmus University Rotterdam8, VU University Amsterdam9, University of Tübingen10, University of Barcelona11, University of Brescia12, University of Navarra13, National Institutes of Health14, Scripps Research Institute15, University of British Columbia16, University of Washington17, Rutgers University18, University of Giessen19, University of Michigan20, University of Würzburg21, Autonomous University of Madrid22, German Center for Neurodegenerative Diseases23, Karolinska Institutet24, University of California, Los Angeles25, Centre national de la recherche scientifique26, French Institute of Health and Medical Research27, Medical University of Vienna28, Sapienza University of Rome29, University of Antwerp30, Mount Sinai Hospital31, Flinders University32, Harvard University33, University of California, San Diego34, Emory University35, Indiana University36, Rush University Medical Center37, University of Toronto38, Baylor College of Medicine39, University of California, San Francisco40, Ludwig Maximilian University of Munich41, University of Kansas42, Mental Health Research Institute43, University of Göttingen44, Cardiff University45, Newcastle University46, University of Manchester47, Innsbruck Medical University48, Carlos III Health Institute49, University of Saskatchewan50, University of Maryland, Baltimore51, University of Cambridge52, University of Alabama at Birmingham53, Veterans Health Administration54, King's College London55, Johns Hopkins University56, Columbia University57, University of Texas Southwestern Medical Center58, University of Southern California59
TL;DR: Two independent variants in MAPT affecting risk for PSP are confirmed, one of which influences MAPT brain expression and the genes implicated encode proteins for vesicle-membrane fusion at the Golgi-endosomal interface and for a myelin structural component.
Abstract: Progressive supranuclear palsy (PSP) is a movement disorder with prominent tau neuropathology. Brain diseases with abnormal tau deposits are called tauopathies, the most common of which is Alzheimer's disease. Environmental causes of tauopathies include repetitive head trauma associated with some sports. To identify common genetic variation contributing to risk for tauopathies, we carried out a genome-wide association study of 1,114 individuals with PSP (cases) and 3,247 controls (stage 1) followed by a second stage in which we genotyped 1,051 cases and 3,560 controls for the stage 1 SNPs that yielded P ≤ 10−3. We found significant previously unidentified signals (P < 5 × 10−8) associated with PSP risk at STX6, EIF2AK3 and MOBP. We confirmed two independent variants in MAPT affecting risk for PSP, one of which influences MAPT brain expression. The genes implicated encode proteins for vesicle-membrane fusion at the Golgi-endosomal interface, for the endoplasmic reticulum unfolded protein response and for a myelin structural component.

504 citations

Journal ArticleDOI
11 Dec 2014-Toxins
TL;DR: An updated overview of the known active Bt toxins to date is provided and a less well characterized secretory protein with no amino acid similarity to Vips has shown insecticidal activity against coleopteran pests and is termed Sip (secreted insecticidal protein).
Abstract: Bacillus thuringiensis (Bt) is a Gram positive, spore-forming bacterium that synthesizes parasporal crystalline inclusions containing Cry and Cyt proteins, some of which are toxic against a wide range of insect orders, nematodes and human-cancer cells. These toxins have been successfully used as bioinsecticides against caterpillars, beetles, and flies, including mosquitoes and blackflies. Bt also synthesizes insecticidal proteins during the vegetative growth phase, which are subsequently secreted into the growth medium. These proteins are commonly known as vegetative insecticidal proteins (Vips) and hold insecticidal activity against lepidopteran, coleopteran and some homopteran pests. A less well characterized secretory protein with no amino acid similarity to Vip proteins has shown insecticidal activity against coleopteran pests and is termed Sip (secreted insecticidal protein). Bin-like and ETX_MTX2-family proteins (Pfam PF03318), which share amino acid similarities with mosquitocidal binary (Bin) and Mtx2 toxins, respectively, from Lysinibacillus sphaericus, are also produced by some Bt strains. In addition, vast numbers of Bt isolates naturally present in the soil and the phylloplane also synthesize crystal proteins whose biological activity is still unknown. In this review, we provide an updated overview of the known active Bt toxins to date and discuss their activities.

504 citations

Journal ArticleDOI
TL;DR: It is concluded that few studies have used designs that permit these different kinds of process to be independently identified, and that presently there is little evidence to indicate which kinds of processing can be fractionated in terms of their neural correlates.

504 citations

Journal ArticleDOI
TL;DR: The recent interest in gold catalysis provides the focus for this perspectives paper as mentioned in this paper, and aspects of both the background to this interest and some of the recent work on gold will be discussed.

503 citations


Authors

Showing all 34629 results

NameH-indexPapersCitations
Rob Knight2011061253207
Stephen V. Faraone1881427140298
John J.V. McMurray1781389184502
David R. Williams1782034138789
John Hardy1771178171694
Dorret I. Boomsma1761507136353
Kay-Tee Khaw1741389138782
Anders Björklund16576984268
Edward T. Bullmore165746112463
Peter A. R. Ade1621387138051
Michael John Owen1601110135795
Gavin Davies1592036149835
Suvadeep Bose154960129071
Todd Adams1541866143110
John R. Hodges14981282709
Network Information
Related Institutions (5)
University of Manchester
168K papers, 6.4M citations

98% related

University College London
210.6K papers, 9.8M citations

97% related

University of Bristol
113.1K papers, 4.9M citations

96% related

University of Edinburgh
151.6K papers, 6.6M citations

95% related

University of Cambridge
282.2K papers, 14.4M citations

95% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
2023139
2022769
20214,868
20204,931
20194,464
20184,379